Back to HomeBeta

ICD-10 Coding for Lung Cancer with Metastases(C34.90, C79.31)

Complete ICD-10-CM coding and documentation guide for Lung Cancer with Metastases. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic Lung CancerLung Cancer with Mets

Related ICD-10 Code Ranges

Complete code families applicable to Lung Cancer with Metastases

C34.0-C34.9Primary Range

Malignant neoplasm of bronchus and lung

Primary code range for lung cancer, specifying the site and laterality of the primary tumor.

Secondary malignant neoplasm of lung

Used when the lung is a site of metastasis from another primary cancer.

Secondary malignant neoplasm of brain

Used for brain metastases originating from a primary lung cancer.

Secondary malignant neoplasm of bone

Used for bone metastases originating from a primary lung cancer.

Malignant (primary) neoplasm, unspecified

Used when the primary site of cancer is unknown.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C34.90Malignant neoplasm of unspecified part of unspecified bronchus or lungUse when the specific site or laterality of the lung cancer is not documented.
  • Pathology report confirming lung origin
  • Imaging studies showing primary lung mass
C79.31Secondary malignant neoplasm of brainUse when brain metastases are confirmed and the primary site is lung.
  • MRI or CT showing brain lesions
  • Documentation of metastatic origin from lung

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for lung cancer with mets

Essential facts and insights about Lung Cancer with Metastases

The ICD-10 code for lung cancer with metastases involves C34.xx for primary lung cancer and C79.xx for metastatic sites.

Primary ICD-10-CM Codes for lung cancer with mets

Malignant neoplasm of unspecified part of unspecified bronchus or lung
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed diagnosis of lung cancer with unspecified site or laterality

Applicable To

  • Lung cancer NOS

Excludes

  • Benign neoplasm of lung (D14.3)

Clinical Validation Requirements

  • Pathology report confirming lung origin
  • Imaging studies showing primary lung mass

Code-Specific Risks

  • Risk of unspecified coding leading to reimbursement issues

Coding Notes

  • Ensure documentation specifies whether the cancer is primary or secondary.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of other malignant neoplasm of bronchus and lung

Z85.118
Use when documenting a history of lung cancer that is no longer active.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Secondary malignant neoplasm of lung

C78.00
Use C78.00 when the lung is a site of metastasis from another primary cancer.

Malignant neoplasm of brain, unspecified

C71.9
Use C71.9 for primary brain tumors, not metastases.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Lung Cancer with Metastases to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C34.90.

Impact

Clinical: Leads to inadequate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims and reduced reimbursement.

Mitigation Strategy

Ensure detailed documentation of cancer sites, Use specific codes whenever possible

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on cancer prevalence and treatment.

Mitigation Strategy

Confirm the origin of the cancer and use C34.xx for primary lung cancers.

Impact

High risk of audits due to use of unspecified codes without justification.

Mitigation Strategy

Use specific codes and ensure thorough documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Lung Cancer with Metastases, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Lung Cancer with Metastases

Use these documentation templates to ensure complete and accurate documentation for Lung Cancer with Metastases. These templates include all required elements for proper coding and billing.

Documenting lung cancer with brain metastases

Specialty: Oncology

Required Elements

  • Primary cancer site and histology
  • Metastatic sites with imaging confirmation
  • Treatment plan and focus

Example Documentation

Patient diagnosed with non-small cell lung cancer (C34.90) with confirmed brain metastases (C79.31). Treatment plan includes chemotherapy for lung and radiation for brain.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Lung cancer with mets
Good Documentation Example
Stage IV non-small cell lung cancer (C34.90) with brain metastasis (C79.31) confirmed by MRI.
Explanation
The good example provides specific staging, histology, and confirmation of metastasis, improving coding accuracy.

Need help with ICD-10 coding for Lung Cancer with Metastases? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more